News About: Pharm. Industry
Kolonn to introduce Chiesi's respiratory medicines
Kolon Pharm and Chiesi Farmaceutici S.p.A. in Italy has recently signed a distirbution agreement to release Chiesi's five respiratory drugs including Foster Formoterol Modulite, an HFA-based pressurised metered-dose i...
Leading drug companies to hold shareholder's meeting on May 25.
Most of the listed pharmaceutical companies having a fiscal year ended at March 31 planned to have their general shareholder's meetings on May 25. Daewoong, Il Dong and Dongwha had achieved favorable business performa...
Government urged to develop bird flu vaccine
Korea needs to start a research and development (R&D) project to find how to prevent bird flu and other infectious diseases among humans and animals, said Kim Yoon-kyung, a patent examiner.
In a recent pandemic inf...
New shape of America's trade policy on pharmaceuticals outlined
The United States is likely to demand re-negotiations in the free trade agreement (FTA) with Korea so as to have some provisions on its labor and environmental standards reflected.
Officials at the U.S. Trade Repre...
Flex time system highly welcome to employees in drug industries.
"Encourage employee's morals with flex times" is a good sign for other many pharmaceutical companies to be pervasive starting from its implementation at some of foreign drug companies.
At present the company where...
Sanofi-Aventis Korea announces availability of oral AmavanSanofi-Aventis Korea announces on May 9 the availability of Amavan (rosiglitazone maleate and glimepiride), a new fixed-dose combination product for type 2 diabetes.
As an ad...
|
Lilly Korea activates adverse drug reaction reporting
All employees of Lilly Korea assume in reporting adverse drug reactions (ADRs), including all reaction to new drugs, during their working hours or daily life.
The company said all employees are obligated to report ...
Foreign drug companies to reinforce self observance program every year.
While local drug companies are swiftly moving their autonomous observance programs after the adoption of CP, the foreign drug corporations also showed that the autonomous compliance programs for their own code of ethi...
Government to proceed with review of generic drugs' filing under KORUS FTA
The government will continue to review the license application of a local pharmaceutical firm, even though the U.S. company that produced the original drug file a lawsuit over patent infringement under the free trade ...
Novartis Korea's Sebivo to be of no NHI reimbursement.
Novartis Korea expressed a deep regret about which the NHI reimbursement for Sebivo (telvibudin), a new therapy of chronic B hepatitis infection, was not granted by the final determination of the Health Insurance Revi...
